Idinvest Partners and Kurma Life Sciences Partners Celebrate Prosensa IPO
Dutch biotechnology company Prosensa Holding has started its first trading day on the Nasdaq New York, US. Prosensa is the second Idinvest portfolio company completing a market listing this year. Earlier in 2013, Erytech Pharma, a French company specialized in innovative therapeutic approach for cancers was admitted on NYSE Euronext Paris.
4 July 2013•1 min read
